Degenerate Audiolivro Por Matt Casamassina capa

Degenerate

Pré-venda com 30% de desconto

Pré-venda: Ouvir com teste grátis
R$ 19,90/mês após o teste gratuito de 30 dias. Cancele a qualquer momento.
Desfrute de forma ilimitada deste título e de uma coleção de mais de 100.000 outros
Escute quando e onde quiser, inclusive offline
Sem compromisso. Cancele quando quiser.

Degenerate

De: Matt Casamassina
Narrado por: Phillip Nathaniel Freeman
Pré-venda: Ouvir com teste grátis

R$ 19,90/mês após o teste gratuito de 30 dias. Cancele a qualquer momento.

Pré-compre agora por R$ 64,99

Pré-compre agora por R$ 64,99

Sobre este título

The latest novel from Matt Casamassina, author of Sophistication, which Kirkus Reviews called "Ambitious. Well-paced. Riveting. [Casamassina] occasionally reaches moments of lyricism.”

Mason Kowalski, a twenty-four year-old copywriter for a San Mateo startup, is on the verge of a nervous breakdown when he inexplicably suffers widespread vision loss in one eye. The doctors say it’s macular degeneration triggered by overwhelming stress, but he wonders if it’s something more, especially when the shadows in his peripheral vision begin to take shape and whisper wonderful and horrible things to him. Is it madness or destiny? The answer could destroy everything and everyone he holds dear.

Journey into the absurd beating heart of Silicon Valley as Mason and his lovable friends try to stop a demented serial killer from murdering more children. Degenerate mashes horror and sci-fi into a twisted, dark, violent and funny pulp drowned in tentacled nightmares. Featuring infamous hijacker DB Cooper and more twists than you can imagine, the genre-breaking story is designed for fans of Stephen King, Blake Crouch, Peter Clines, Keith Rosson, Chuck Wendig and John Scalzi.

©2025 Matt Casamassina (P)2025 Matt Casamassina
Ficção Científica Pós-Apocalíptico

Resumo da Crítica

“As ambitious as it is unpredictable.” - Kirkus Reviews

“A resolutely unclassifiable epic from Casamassina that blends genres into the wildest of elixirs.” - Publishers Weekly

Ainda não há avaliações